The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome

Carlioglu, Ayse; Kaygusuz, Ikbal; Karakurt, Feridun; Gumus, Ilknur; Uysal, Aysel; KASAPOĞLU, BENAN; Armutcu, Ferah; Uysal, Sema; Keskin, Esra; Koca, Cemile

doi:10.1007/s00404-014-3275-8

The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome

Atıf İçin Kopyala

Carlioglu A., Kaygusuz I., Karakurt F., Gumus I. I., Uysal A., KASAPOĞLU B., ...Daha Fazla

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.290, sa.5, ss.929-935, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 290 Sayı: 5
Basım Tarihi: 2014
Doi Numarası: 10.1007/s00404-014-3275-8
Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.929-935
Anahtar Kelimeler: Polycystic ovary syndrome, Platelet activating factor acetyl hydrolyze, Oxidized LDL, Paraoxonase1, Paraoxonase1 phenotypes, Arylesterase, CORONARY-ARTERY-DISEASE, ACETYLHYDROLASE PAF-AH, INTIMA-MEDIA THICKNESS, RISK-FACTOR, CARDIOVASCULAR-DISEASE, INSULIN-RESISTANCE, HEART-DISEASE, CHRONIC INFLAMMATION, PHOSPHOLIPASE A(2), OXIDATIVE STRESS
Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Purpose To evaluate the platelet activating factor acetyl hydrolyze (PAF-AH), oxidized low-density lipoprotein (ox-LDL), paraoxonase 1 (PON1), arylesterase (ARE) levels and the effects of metformin and Diane-35 (ethinyl oestradiol + cyproterone acetate) therapies on these parameters and to determine the PON1 polymorphisms among PCOS patients.